Dr. Yoav Shechter עברית

Twenty-five years in policy advocacy, across the world.

Policy advocacy is a profession.

A proven method that can be managed and measured — for companies whose performance is shaped by regulation.

Dr. Yoav Shechter
PhD, London School of Economics — on lobbying in the European Union Government affairs teams across 100+ countries Founder, Pugatch Consilium AI for Policy Engine Chair, Healthcare Committee, AmCham Russia

Four services, four kinds of answer.

Strategic, operational, educational and technological. Each stands on its own — take one, or combine them according to what the organisation needs at the time.

01

Feasibility analysis and strategy

First I analyse whether your policy objective is achievable at all. On that understanding we build a practical strategy for execution — an operational plan covering government affairs, public relations and content.

02

Ongoing advocacy to the objective

Directing and coordinating everyone in the campaign — from the company's own leadership, through campaign partners, to running the meetings with decision-makers.

03

Workshops and executive training

Building the capability inside the organisation — the tools, the method, and the order of work in front of regulators.

04

Building AI for policy work

Specification, construction and deployment of an AI system for policy work, inside your organisation and built to your needs. It stays yours.

Where I have worked

Policy advocacy across health, pharmaceuticals, technology and intellectual property — in Europe, in Asia-Pacific, and from inside multinational structures responsible for more than a hundred countries.

The European Union

My doctoral research at the London School of Economics examined lobbying in the European Union — how influence actually works across its institutions, rather than how it is described.

  • Doctorate · LSE, on EU lobbying
  • Teaching · universities and guest lectures on policy advocacy

Asia-Pacific and beyond

Advancing policy on health, pharmaceuticals, technology and intellectual property across markets with very different regulatory cultures — and chairing an industry committee inside one of them.

  • Markets · Korea, Japan, China, India, Singapore, Thailand, Australia, Russia
  • Chair · Healthcare Committee, American Chamber of Commerce in Russia

I build AI for policy work — inside your organisation.

A system specified to your needs, built inside the organisation, connected to the way you already work, and operated by your own team. It stays yours.

Specification

Working out what the organisation actually needs the system to do — and what it does not. This is the stage that decides whether it gets used or abandoned.

Build and deployment

Standing the system up in your environment and connecting it to existing workflows rather than beside them.

Handover

Training your team to run, adjust and extend it. Success is measured by your not needing me.

The short route is a thirty-minute conversation.

Tell me where it hurts in the regulatory arena — where you are stuck, what it is costing you, what is unfair to you, and what you would want to change.

Providing these details is voluntary, not a legal requirement. They are used only to reply to your enquiry, are not passed to any third party and are not used for marketing. Full details in the privacy policy.